Physician Wealth Advisors’s Parker-Hannifin PH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134K Sell
140
-1
-0.7% -$982 0.02% 280
2026
Q2
$138K Buy
141
+5
+4% +$4.58K 0.02% 268
2026
Q1
$122K Buy
136
+2
+1% +$1.89K 0.02% 252
2025
Q4
$118K Buy
134
+5
+4% +$4.09K 0.02% 253
2025
Q3
$97.8K Buy
129
+35
+37% +$25.8K 0.01% 275
2025
Q2
$65.7K Buy
94
+5
+6% +$3.16K 0.01% 310
2025
Q1
$54.1K Sell
89
-37
-29% -$24.2K 0.01% 320
2024
Q4
$80.1K Buy
+126
New +$83.4K 0.01% 284

Other funds holding PH

Physician Wealth Advisors's PH Position: Q3 2026 in Review

Physician Wealth Advisors reduced its Parker-Hannifin (PH) stake by 0.71% in Q3 2026, selling an estimated $982 and leaving 140 shares worth $134K. The position accounts for 0.02% of the portfolio, ranked #280.

Physician Wealth Advisors first reported a position in PH in Q4 2024 and has held it in 8 quarters since. The position peaked at $138K in Q2 2026. 1,976 funds tracked by Wall St. Rank hold PH as of Q3 2026.

  • Physician Wealth Advisors held 140 shares of Parker-Hannifin worth $134K as of Q3 2026.
  • Physician Wealth Advisors sold 1 Parker-Hannifin share in Q3 2026, an estimated $982.
  • Parker-Hannifin made up 0.02% of Physician Wealth Advisors's portfolio in Q3 2026, its #280 holding.
  • Physician Wealth Advisors first reported a position in Parker-Hannifin in Q4 2024 and has held it in 8 quarters since.
  • Physician Wealth Advisors's Parker-Hannifin position peaked at $138K in Q2 2026.
  • 1,976 funds tracked by Wall St. Rank held Parker-Hannifin as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.